New Edge Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

New Edge Advisors, LLC

  • $16.2 Billion
  • Q1 2025

A detailed history of New Edge Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, New Edge Advisors, LLC holds 34,586 shares of TEVA stock, worth $627,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,586
Previous 35,482 2.53%
Holding current value
$627,735
Previous $782,000 32.1%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$14.67 - $22.01 $13,144 - $19,720
-896 Reduced 2.53%
34,586 $531,000
Q4 2024

Feb 13, 2025
BUY
$16.43 - $22.77 $65,440 - $90,692
3,983 Added 12.64%
35,482 $782,000
Q3 2024

Nov 14, 2024
SELL
$15.81 - $18.96 $664 - $796
-42 Reduced 0.13%
31,499 $567,000
Q2 2024

Aug 15, 2024
BUY
$12.78 - $17.4 $274,565 - $373,821
21,484 Added 213.62%
31,541 $512,000
Q1 2024

May 14, 2024
BUY
$10.67 - $14.43 $76,770 - $103,823
7,195 Added 251.4%
10,057 $141,000
Q4 2023

Feb 13, 2024
BUY
$8.12 - $10.63 $917 - $1,201
113 Added 4.11%
2,862 $29,000
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $81,352 - $116,373
-10,876 Reduced 79.82%
2,749 $28,000
Q2 2023

Aug 14, 2023
BUY
$7.2 - $9.47 $12,146 - $15,975
1,687 Added 14.13%
13,625 $102,000
Q1 2023

May 12, 2023
BUY
$8.36 - $11.37 $49,574 - $67,424
5,930 Added 98.7%
11,938 $105,000
Q4 2022

Feb 14, 2023
BUY
$7.95 - $9.48 $47,763 - $56,955
6,008 New
6,008 $54,000
Q3 2017

Nov 13, 2017
SELL
$15.41 - $32.17 $12,574 - $26,250
-816 Closed
0 $0
Q2 2017

Aug 16, 2017
BUY
N/A
816
816 $0

Others Institutions Holding TEVA

# of Institutions
660
Shares Held
626M
Call Options Held
27.9M
Put Options Held
21.8M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email